CPT vs LXP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CPT

39.2
AI Score
VS
LXP Wins

LXP

51.5
AI Score

Investment Advisor Scores

CPT

39score
Recommendation
AVOID NEW MONEY

LXP

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CPT LXP Winner
Forward P/E 62.5 28.9017 LXP
PEG Ratio 9.1681 3.1481 LXP
Revenue Growth -2.3% 4.5% LXP
Earnings Growth 771.3% 159.8% CPT
Tradestie Score 39.2/100 51.5/100 LXP
Profit Margin 71.1% 34.3% CPT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD LXP

Relative Price Performance (Last 90 Days)

CPT 1M: +1.1% · 3M: -10.3% LXP 1M: +0.4% · 3M: +1.2%

Current Technical Phase

CPT

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.0%) with fading momentum, RSI 45

RSI (14): 45.5 · Price: $99.09

LXP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 72

RSI (14): 71.6 · Price: $61.18

Fundamentals Snapshot

Metric CPT LXP
Market Cap — —
Forward P/E 215.4 117.1
Trailing P/E 9.3 31.2
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.2% 0.1%
EPS 10.70 1.96
Dividend Yield 0.04% 0.04%

Frequently Asked Questions

Based on our detailed analysis, LXP is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.